910 related articles for article (PubMed ID: 18361212)
41. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial.
Auerbach SR; Richmond ME; Lamour JM; Blume ED; Addonizio LJ; Shaddy RE; Mahony L; Pahl E; Hsu DT
Circ Heart Fail; 2010 Sep; 3(5):606-11. PubMed ID: 20573993
[TBL] [Abstract][Full Text] [Related]
42. Plasma B-type natriuretic peptide concentration in beta-thalassaemia patients.
Aessopos A; Farmakis D; Polonifi A; Tsironi M; Fragodimitri C; Hatziliami A; Karagiorga M; Diamanti-Kandarakis E
Eur J Heart Fail; 2007 May; 9(5):537-41. PubMed ID: 17300987
[TBL] [Abstract][Full Text] [Related]
43. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
El-Saed A; Voigt A; Shalaby A
Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
[TBL] [Abstract][Full Text] [Related]
45. [BNP and echocardiography can predict the occurrence of acute cardiac decompensation during titration of bisoprolol in chronic systolic heart failure].
Ben Driss A; Tabet JY; Meurin P; Weber H; Renaud N; Grosdemouge A; Bourmayan C
Arch Mal Coeur Vaiss; 2007 Nov; 100(11):934-40. PubMed ID: 18209694
[TBL] [Abstract][Full Text] [Related]
46. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
[TBL] [Abstract][Full Text] [Related]
47. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
[TBL] [Abstract][Full Text] [Related]
48. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
[TBL] [Abstract][Full Text] [Related]
49. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
[TBL] [Abstract][Full Text] [Related]
50. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
[TBL] [Abstract][Full Text] [Related]
51. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.
Vanderheyden M; Mullens W; Delrue L; Goethals M; de Bruyne B; Wijns W; Geelen P; Verstreken S; Wellens F; Bartunek J
J Am Coll Cardiol; 2008 Jan; 51(2):129-36. PubMed ID: 18191736
[TBL] [Abstract][Full Text] [Related]
52. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke.
Koenig MA; Puttgen HA; Prabhakaran V; Reich D; Stevens RD
Intensive Care Med; 2007 Sep; 33(9):1587-93. PubMed ID: 17541542
[TBL] [Abstract][Full Text] [Related]
53. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.
Ishii J; Nomura M; Nakamura Y; Naruse H; Mori Y; Ishikawa T; Ando T; Kurokawa H; Kondo T; Nagamura Y; Ezaki K; Hishida H
Am J Cardiol; 2002 Mar; 89(6):691-5. PubMed ID: 11897211
[TBL] [Abstract][Full Text] [Related]
54. B-type natriuretic peptide may predict prognosis in older adults admitted with a diagnosis other than heart failure.
Di Marca S; Rando A; Cataudella E; Pulvirenti A; Alaimo S; Terranova V; Corriere T; Pisano M; Di Quattro R; Ronsisvalle ML; Giraffa CM; Giordano M; Stancanelli B; Malatino L
Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):636-642. PubMed ID: 29625779
[TBL] [Abstract][Full Text] [Related]
55. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.
Koitabashi T; Inomata T; Niwano S; Nishii M; Takeuchi I; Nakano H; Shinagawa H; Takehana H; Izumi T
Int Heart J; 2005 May; 46(3):453-64. PubMed ID: 16043941
[TBL] [Abstract][Full Text] [Related]
56. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
[TBL] [Abstract][Full Text] [Related]
57. Plasma brain natriuretic peptide--an independent predictor of cardiovascular mortality in acute heart failure.
Yu CM; Sanderson JE
Eur J Heart Fail; 1999 Mar; 1(1):59-65. PubMed ID: 10937981
[TBL] [Abstract][Full Text] [Related]
58. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
59. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
[TBL] [Abstract][Full Text] [Related]
60. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
